IBI363 Combined With Bevacizumab for Advanced Colorectal Cancer

Clinical trial NCT07722494 · RECRUITING

Trial details

NCT number: NCT07722494
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2026-07-31
Primary completion: 2028-10-31
Enrollment: 550

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.